Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2001
Business Overview: A leading manufacturer and distributor of prestige and mass market fragrances, cosmetics, and personal care products. The company operates globally with significant exposure to European markets.
Key Financial Metrics (Six Months Ended June 30, 2001)
| Metric | Value (USD) |
|---|---|
| Net Sales | $57,302,939 |
| Gross Margin | $28,172,542 (49% of sales) |
| Income from Operations | $7,070,150 |
| Net Income (Consolidated) | $3,972,655 |
| Net Income Per Share (Diluted) | $0.30 |
| Cash and Cash Equivalents | $28,782,777 |
| Working Capital | $58,969,243 |
| Long-Term Debt | $1,319,050 |
| Bank Loans (Current) | $5,608,518 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 23% to $57.3 million compared to $46.4 million in the prior year period. On a constant currency basis, sales grew 29%.
- Profitability: Net income rose 36% to $4.0 million from $2.9 million. Diluted EPS increased 30% to $0.30 from $0.23.
- Margin Expansion: Gross margin improved to 49% from 47% in the prior year, driven by a stronger US dollar against the Euro and a higher mix of prestige products.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased to $21.1 million from $16.7 million, primarily due to increased advertising and promotion for new product launches (Burberry Touch, Paul Smith).
- Cash Flow: Net cash provided by operating activities turned positive at $0.2 million, compared to a use of $3.1 million in the prior year, aided by favorable vendor payment terms.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Product Pipeline: New launches include a Burberry Touch bath line (shipped late June 2001), two new Celine fragrances (Q4 2001), and a FUBU fragrance line (Jan 2002).
- Capital Allocation: The Board approved a 3-for-2 stock split (50% stock dividend) payable September 14, 2001.
- Liquidity: Management cites a strong financial position with a working capital ratio of nearly 3:1 and sufficient resources to meet future needs without additional financing.
Risks and Contingencies
- Litigation: Ongoing appeal regarding the "Ombre Rose" trademark with Jean Charles Brosseau, S.A. A $600,000 charge was taken in 2000. Management does not expect further material adverse effects, though an additional $142,000 advance for damages was required in February 2001.
- Currency Risk: Significant exposure to foreign currency fluctuations, particularly the US dollar vs. the Euro/French Franc. The company uses forward exchange contracts to hedge receivables.
- Market Risk: Dependence on consumer acceptance of new products and competition in the fragrance industry.
Investor Verification Checklist
- Constant Currency Growth: Verify the 29% constant currency sales growth rate to understand organic performance independent of exchange rate fluctuations.
- Inventory Build: Review the $7.0 million increase in inventory levels to ensure it aligns with anticipated sales growth and does not signal future obsolescence.
- Litigation Status: Monitor the outcome of the Brosseau appeal to confirm no further financial charges are required beyond the $142,000 advance.
- Stock Split Impact: Confirm the execution of the 3-for-2 stock split and its effect on share price and liquidity.
- Debt Structure: Note the increase in bank loans payable from $2.5 million to $5.6 million and the utilization of the $12 million credit facility.